Clinical Trials
- Lymphoma, Leukemia
Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release
- Lymphoma
test
- Kidney Cancer, Phase 1 Cancers
Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003
- Lung Cancer
Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
- Lymphoma
test
- Stomach and Esophagus, Head and Neck Cancers
test
- Lung Cancer
test
- Phase 1 Cancers
test
- Leukemia, Pediatric Cancers
test
- Lymphoma
test
- Ages18 years - 70 years
- GenderBoth